HYIP-Man: DARPA and Harvard ink $16 million agreement to identify and test FDA-approved drugs for COVID-19
Tuesday, June 16, 2020
DARPA and Harvard ink $16 million agreement to identify and test FDA-approved drugs for COVID-19

DARPA and Harvard ink $16 million agreement to identify and test FDA-approved drugs for COVID-19


The U.S. Defense Advanced Research Projects Agency has inked a deal with Harvard's Wyss Institute worth up to $16 million to use technology to identify and test FDA-approved drugs that could be used in the battle against COVID-19.

Written at 10:08 PM by Frank.
0 comments